Off-Label Prescriptions in Italian Hospices: A National Survey

Journal of Pain and Symptom Management

Volumn 38, Issue 3, 2009, Pages 365-371

  Toscani, Franco ^a   Di Giulio, Paola ^b   Campi, Rita ^c   Pellerin, Ivanoe ^d   De Luca, Anna ^e   Casale, Giuseppe ^f  

^a Lino Maestroni Foundation Palliative Medicine Research Institute   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d Hospital of Legnano   (Italy)

^e MOLINETTE HOSPITAL   (Italy)

^f Antea Formad   (Italy)

Author keywords

hospice; Off label; palliative medicine; prescriptions in hospices; SC drugs; symptomatic prescriptions

Indexed keywords

BETAMETHASONE; BROMAZEPAM; CLONAZEPAM; DEXAMETHASONE; DIAZEPAM; FENTANYL; HYDROCORTISONE; METHYLPREDNISOLONE; MORPHINE; MORPHINE SULFATE; PREDNISOLONE;

ANOREXIA; ARTICLE; ASTHENIA; CACHEXIA; DRUG MARKETING; DYSPNEA; HEALTH SURVEY; HOSPICE; HOSPITAL PATIENT; HUMAN; ITALY; MEDICAL PRACTICE; NEUROPATHIC PAIN; OFF LABEL DRUG USE; PALLIATIVE THERAPY; PRESCRIPTION;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HOSPICES; HUMANS; ITALY; MALE; MIDDLE AGED; OFF-LABEL USE; TERMINAL CARE;

EID: 69549135384     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2008.11.014     Document Type: Article

References (32)

1. Atkinson C.V., and Kirkham S.R. Unlicensed uses for medication in a palliative care unit. Palliat Med 13 (1999) 145-152
2. Davis M.P. Palliative medicine: old dogs and new tricks. Cleve Clin J Med 67 (2000) 557-559
3. Radley D.C., Finkelstein S.N., and Stafford R.S. Off-label prescribing among office-based physicians. Arch Intern Med 166 (2006) 1021-1026
4. Trifirò G., Spina E., Brignoli O., et al. Antipsychotic prescribing patterns among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol 61 (2005) 47-53
5. Kogut S.J., Yam F., and Dufresne R. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. J Manag Care Pharm 11 (2005) 17-24
6. Haw C., and Stubbs J. A survey of the off-label use of mood stabilizers in a large psychiatric hospital. J Psychopharmacol 19 (2005) 402-407
7. Pavis H., and Wilcock A. Prescribing of drugs for use outside their license in palliative care: survey of specialists in the United Kingdom. BMJ 323 (2001) 484-485
8. Weschules D.J., Maxwell T., Reifsnyder J., and Knowlton C.H. Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?. Am J Hosp Palliat Care 23 (2006) 135-149
9. Todd J., and Davies A. Use of unlicensed medication in palliative medicine. Palliat Med 13 (1999) 446
10. Fonzo-Christe C., Vukasovic C., Wasilewski-Rasca A.F., and Bonnabry P. Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat Med 19 (2005) 208-219
11. O'Doherty C.A., Hall E.J., Schofield L., and Zeppetella G. Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire. Palliat Med 15 (2001) 149-154
12. Zachrisson U., and Fürst C.J. Drug infusors in palliative medicine: a Swedish inquiry. J Pain Symptom Manage 15 (1998) 299-304
13. Cherny N.J., Chang V., Frager G., et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 76 (1995) 1283-1293
14. Art. 3, comma 2, Law 8 April 1998, n. 94. Gazzetta Ufficiale 1998; 86 (April 14, 1998). Available at: http://www.camera.it/parlam/leggi/980941.htm. Accessed June 24, 2009.
15. Società Italiana di cure palliative. Hospice in Italia. Prima rilevazione ufficiale 2006. Available at: http://www.sicp.it/hospice_menu.asp. Accessed June 24, 2009.
16. OEMF. REFI-Repertorio Farmacologico Italiano (CD-ROM). 13th ed. (2003), OEMF-Masson, Milan, Italy
17. Agenzia Italiana del Farmaco. PFN 2005 (2005), Istituto Poligrafico dello Stato, Rome
18. Twycross R., Wilcock A., Charlesworth S., and Dickman A. Palliative care formulary. 2nd ed. (2002), Radcliffe Medical Press, Abingdon
19. In: Metha D.K. (Ed). British national formulary. 48th ed. (2004), Pharmaceutical Press, London
20. Ferner R.E. Prescribing licensed medicines for unlicensed indications. Prescriber's J 36 (1996) 73-79
21. Back I.N., Jenkins K., Blower A., and Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 15 (2001) 329-336
22. Janssens J.P., de Muralt B., and Titelion V.J. Management of dyspnea in severe chronic obstructive pulmonary disease. J Pain Symptom Manage 19 (2000) 378-392
23. Jennings A.L., Davies A.N., Higgins J.P., Gibbs J.S., and Broadley K.E. A systematic review of the use of opioids in the management of dyspnoea. Thorax 57 (2002) 939-944
24. Vadell C., Seguí M.A., Giménez-Arnau J.M., et al. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol 21 (1998) 347-351
25. Myers K.G., and Trotman I.F. Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. Postgrad Med J 70 (1994) 359-362
26. Hughes A., Wilcock A., and Corcoran R. Ketorolac: continuous subcutaneous infusion for cancer pain. J Pain Symptom Manage 13 (1997) 315-316
27. Morichon E. Guide to the administration of subcutaneous drugs. (French) Bulletin. d'Information du médicament et de pharmacovigilance 128 (2006) 1-6
28. Jonhson I., and Patterson S. Drugs used in combination in the syringe driver. Palliat Med 6 (1992) 125-130
29. O'Neill W.M. Subcutaneous infusion-a medical last rite. Palliat Med 8 (1994) 91-93
30. Wilcock A., Jacob J.K., Charlesworth S., et al. Drugs given by a syringe driver: a prospective multicentre survey of palliative care services in the UK. Palliat Med 20 (2006) 661-664
31. Drummond S.H., Peterson G.M., Galloway J.G., and Keefe P.A. National survey of drug use in palliative care. Palliat Med 10 (1996) 119-124
32. Good P.D., Schneider J.J., and Ravenscroft P.J. The compatibility and stability of midazolam and dexamethasone in infusion solutions. J Pain Symptom Manage 27 (2004) 471-475